1. Drug database and performance indicators for utilization monitoringby
Petcharat Pongcharoensuk, et al.
Faculty of Pharmacy, Mahidol University
Sponsor: The National Health Security Office
4/1/04
ICIUM2004_CM

2. Introduction Drugs, 30% of health expenses
Drug database in hospitals (purchasing and dispensing)
Limited utility
Lack standard format and code
Insufficient information technology
“Drug information for decision making”
4/1/04
ICIUM2004_CM

3. Objective
To determine key performance indicators for drug utilization monitoring
Total purchase
ratio ED:NED
by drug group, etc.
Unit price statistics
4/1/04
ICIUM2004_CM

4. Methodology Sample: 26 public hospitals (10-1000 bed)
5 small, 21 medium and large
Source: Electronic purchase database ( )
Data transformation (mapping different codes into standard code)
Data consolidation and analysis
4/1/04
ICIUM2004_CM

5. Results: Key performance indicators
4/1/04
Results: Key performance indicators
I. Total drug purchase (million baht)
Year Purchase %change
(adjusted*) (adjusted*)
(898.4) (9.9)
(947.7) (5.6)
Notes: *adjusted for inflation of 1.1% in 2001 and 1.9% in 2002 (NESDB).
4/1/04
ICIUM2004_CM
ICIUM2004_CM

6. II. Drug as % total expenses, 2002
Type of Hospital (bed) N Range % Avg.
Regional ( )
General ( )
Community (10-90)
4/1/04
ICIUM2004_CM

7. III. Ratio NED:ED -----------------------------------------
Year Ratio (NED:ED)
: 85
: 83
: 82
4/1/04
ICIUM2004_CM

8. IV. Pharmacological sub-groups (%)
Rank Group
1 Anti-bacterials
3 Anti-asthma
4 Anti-diabetics
5 Hypo-lipidemic
6 Anti-anaemic
8 NSAIDS
10 Cytostatic
Total (million)
4/1/04
ICIUM2004_CM

9. V. Unit price statistics
Drug N Min Max Avg. p50 p75
Aledronate 10 mg tab
Alprazolam .25 mg tab
Atorvastatin 20 mg tab
Captopril 25 mg tab
Cefoperazone 1 g inj
Ceftriaxone 1 g inj
Ciprofloxacin 250 mg tab
Simvastatin 10 mg tab
Rosiglitazone 4 mg tab
4/1/04
ICIUM2004_CM

10. Discussions Lesson learned Policy implications
Urgent need for data management and policy implementations
Policy implications
Central data warehouse (MoPH?)
Agency for standard drug code (FDA?)
Quantity and quality indicators
4/1/04
ICIUM2004_CM

11. Recommendations Research Systematic management of drugs
Cost of illness and quality of drug use
Outcomes of treatment
Systematic management of drugs
4/1/04
ICIUM2004_CM

12. Ms Pornpimol Chantarakunopars
Acknowledgement
Team
Mr Mungorn Angsanant
Ms Pornpimol Chantarakunopars
Preeyaporn Phutong
Siritorn Kongsawat
Etc.
4/1/04
ICIUM2004_CM